Ronald Kershner to join AAIPharma
This article was originally published in Scrip
Ronald Kershner has joined AAIPharma (US) to lead the company's North American biostatistics and data management services groups. He has more than 25 years' industry experience working in large pharmaceutical, biotechnology and contract research companies. In previous roles with inVentiv, Inveresk and Omnicare, Mr Kershner was responsible for the oversight of biostatistics and data management across various therapeutic areas.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.